New scan could sharpen picture of blood cancer

NCT ID NCT04561492

Recruiting now Diagnosis Sponsor: Nantes University Hospital Source: ClinicalTrials.gov ↗

Summary

This study is testing a new type of PET scan to see if it can better detect and track multiple myeloma, a type of blood cancer. It will compare the new scan, which uses a tracer called [68Ga]Ga-PentixaFor, to a standard FDG-PET scan in 45 patients who are either newly diagnosed or have relapsed. The goal is to see if the new scan is more accurate at finding cancer spots and predicting how patients will respond to treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

APHP - Site Tenon
RECRUITING

Paris, France

Contact Email: •••••@•••••
CHU Bordeaux
RECRUITING

Bordeaux, France

Contact Email: •••••@•••••
CHU Lille
NOT_YET_RECRUITING

Lille, France

Contact Email: •••••@•••••
HCL
NOT_YET_RECRUITING

Lyon, France

Contact Email: •••••@•••••
Nantes UH
RECRUITING

Nantes, France

Contact

Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

MULTIPLE MYELOMA